If you work in the biotech industry, you might know the name Alex Denner. If not, his name probably doesn’t ring a bell. ...

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...

The round, which included more than a dozen investment firms, should give the startup enough cash to get late-stage data for ...

In this article, we will be taking a look at the 15 best biotech stocks to buy according to billionaires. Although biotech ...

Ionis’ drug, called sapablursen, is currently being tested in a Phase 2 trial in people with polycythemia vera.